Bluebee

White paper: Bluebee Data security and compliance

Bluebee offers a global bio-informatics platform to process, analyze, share and store genomics data. With a private cloud service, Bluebee supports users in clinical diagnostics, therapeutics and research with advanced analytics for genomic data driven medicine. Designed for cross-functional teams of clinicians and life science researchers the Bluebee platform effectively centralizes and manages genomics data processes and storage. Bluebee’s multi-layered …

BioData World Congress

Interview with the President of the European Institute for Innovation through Health Data

The interview was conducted by the DNAdigest team (dnadigest.org) Dipak Kalra is the President of the European Institute for Innovation through Health Data (i~HD). He is also a Professor of Health Informatics at University College London, and  affiliated with University of Gent. He has worked on the clinical, ethical and legal requirements for electronic health records and on the development of international interoperability standards and will present …

Re-Imagining Drug Safety Powered by Genomics, Information Integration and Emerging Technologies

|| Whitepaper by Tata Consultancy Services. Pub. 17/08/2017 Abstract Scientific advancements, emerging technologies, and extensive information have created new opportunities for modernizing drug safety.  Simultaneously, the pharmacovigilance regulatory landscape is shifting to ensure improved safety for patients. This is the time to reimagine the  drug safety sector to transform it into an advanced, proactive and patient-centric practice. Introduction The global …

DNA Digest

Interview with Head of ELIXIR’s Human Genomics and Translational Data

Our supporting partner DNAdigest got in touch with one of our speakers at BioData World Congress– Serena Scollen, Head of Human Genomics and Translational Data at ELIXIR. Serena will be speaking about maximising opportunities to use human genomics data and about how ELIXIR enables this through European collaborations. We want to share some snippets of the interview and you will be able to access …

An insight into NIH’s Big Data to Knowledge project

DNAdigest– official supporter of BioData World Congress USA, interviewed Phil Bourne – Associate Director for Data Science at the National Institutes of Health about the Big Data to Knowledge (BD2K) project. What is Big Data to Knowledge (BD2K)? “BD2K is an NIH program across 27 institutes of about 110 million dollars a year. The program focus is on the challenges emerging in data across biosciences, …

Download White Paper : Translating Cancer Genomics for personalized approach to treating cancer

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.The study of cancer genomics has …

Moving Towards Personalised Medicine with Big Data Strategies

  The use of Big Data strategies is thought to have the potential to help physicians and scientists move closer to treating individuals, rather than diseases. Developing treatments that are tailored to an individual’s history and sensitivities presents many challenges, and will only be possible within a digital health care system. An article from 20 January 2011 in the U.S. News & World …

Re-Imagining Drug Safety Powered by Genomics, Information Integration and Emerging Technologies

The global healthcare environment is undergoing transformation across the care delivery eco-system to provide more affordable and quality healthcare to all. The paper focusses on the next-generation drug safety models, and outlines the direction for realizing the emerging vision. Scientific advancements, emerging technologies and availability of large amount of information from different sources are offering newer opportunities for modernizing drug …

tcs, drug safety, genomics, technology, world drug safety congress europe

Re-imagining Drug Safety

Re-imaginging Drug Safety: Powered by Genomics, Information Integration & Emerging Technologies by Debashis Ghosh, President – Life Science, Manufacturing and Energy, Tata Consultancy Services The video covers: Changing context Genomics and drug safety Information and insights integration Next generation drug safety architecture using emerging technologies Regulatory direction Putting it all together For more information on Drug Safety, join us at the …

The future of pharma innovation: Genomic medicine

The future of drug development is undoubtedly tied to personalizing medicine. Understanding a person’s genetic makeup in order to not only detect but treat diseases is at the forefront of medicine nowadays. The Mexican pharma industry has joined this trend as several companies are joining efforts with research institutions to look at the diversity of genetic profiles in the Mexican …